Black gay men face major PrEP access gaps due to cost, stigma, mistrust, and provider silence—despite high HIV impact; ...

The quest for a single-pill once-a-day treatment for HIV became a reality when the FDA approved Atripla on July 12. It combines the already approved drugs efavirenz (Sustiva), tenofovir (Viread), and ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...

Observers are calling proposed changes to state-funded HIV assistance its biggest rollback since the aid went into place.

HUNTSVILLE, AL (WAFF) - Sept. 18 marks National HIV/AIDS and Aging Awareness Day. Older Americans are more likely than younger Americans to be diagnosed with HIV infection late in the course of their ...

MSD’s once-daily pill for human immunodeficiency virus (HIV) has proved non-inferior to Gilead’s Biktarvy (bictegravir/emtricitabine/tenofovir alafenamidei) in a ...

Advocacy groups from 30 countries are urging Merck to create a global access strategy for its once-a-month HIV prevention ...

By Chris Takudzwa Muronzi HARARE, Feb 19 (Reuters) - Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the country one of the first ...

The Food and Drug Administration on Monday approved the first drug shown to reduce the risk of HIV infection, the latest milestone in the 30-year battle against the virus that causes AIDS. The agency ...

Florida's state-funded HIV drug assistance program is facing a significant rollback, impacting drug availability and ...